<DOC>
	<DOCNO>NCT01710878</DOCNO>
	<brief_summary>Safety performance anti-microbial vascular graft treatment aneurysmal occlusive disease abdominal aorta .</brief_summary>
	<brief_title>Performance Safety Second Generation Antimicrobial Graft Abdominal Position</brief_title>
	<detailed_description>The purpose multi center , single arm study demonstrate safety performance Second Generation Anti-Microbial ( InterGard Synergy ) vascular graft treatment aneurismal occlusive disease abdominal aorta . The primary endpoint assessment primary secondary graft patency . The secondary endpoint assessment adverse event assessment triclosan silver content serum time .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Patient age 1885 year Patient present aortoiliac occlusion ( obstruction flow ) stenosis , aortoiliac aneurysm eligible revascularization bifurcate graft Patient treat emergency Patient include another investigation Patient pregnant lactate woman childbearing potential Patient know allergy material device use ( collagen , triclosan , silver ) Patient previous aortoiliac bypass replacement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>